These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 11439734

  • 21. Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protocol 035 Study Group.
    Cannon GW, Caldwell JR, Holt P, McLean B, Seidenberg B, Bolognese J, Ehrich E, Mukhopadhyay S, Daniels B.
    Arthritis Rheum; 2000 May; 43(5):978-87. PubMed ID: 10817549
    [Abstract] [Full Text] [Related]

  • 22. The effect of health related quality of life on reported use of health care resources in patients with osteoarthritis and rheumatoid arthritis: a longitudinal analysis.
    Ethgen O, Kahler KH, Kong SX, Reginster JY, Wolfe F.
    J Rheumatol; 2002 Jun; 29(6):1147-55. PubMed ID: 12064827
    [Abstract] [Full Text] [Related]

  • 23. A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis.
    Nickel JC, Pontari M, Moon T, Gittelman M, Malek G, Farrington J, Pearson J, Krupa D, Bach M, Drisko J, Rofecoxib Prostatitis Investigator Team.
    J Urol; 2003 Apr; 169(4):1401-5. PubMed ID: 12629372
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee.
    Babul N, Noveck R, Chipman H, Roth SH, Gana T, Albert K.
    J Pain Symptom Manage; 2004 Jul; 28(1):59-71. PubMed ID: 15223085
    [Abstract] [Full Text] [Related]

  • 25. Patient and physician satisfaction with rofecoxib in osteoarthritis: results of the EVA (experience with VIOXX in arthritis) survey.
    Steinfeld S, Poriau S.
    Curr Med Res Opin; 2001 Jul; 17(2):81-7. PubMed ID: 11759186
    [Abstract] [Full Text] [Related]

  • 26. A randomized, double-blind, placebo-controlled trial of the effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients.
    Higuchi T, Iwama T, Yoshinaga K, Toyooka M, Taketo MM, Sugihara K.
    Clin Cancer Res; 2003 Oct 15; 9(13):4756-60. PubMed ID: 14581346
    [Abstract] [Full Text] [Related]

  • 27. Experience of rofecoxib in patients with osteoarthritis previously treated with traditional non-steroidal anti-inflammatory drugs in Spain: results of phase 2 of the VICOXX study.
    Arboleya LR, de la Figuera E, Soledad García M, Aragón B, VICOXX Study Group.
    Curr Med Res Opin; 2003 Oct 15; 19(4):288-97. PubMed ID: 12841921
    [Abstract] [Full Text] [Related]

  • 28. Improved control of osteoarthritis pain and self-reported health status in non-responders to celecoxib switched to rofecoxib: results of PAVIA, an open-label post-marketing survey in Spain.
    Collantes-Estevez E, Fernandez-Perez C.
    Curr Med Res Opin; 2003 Oct 15; 19(5):402-10. PubMed ID: 13678477
    [Abstract] [Full Text] [Related]

  • 29. Discriminant validity of the Western Ontario and McMaster Universities Osteoarthritis index physical functioning subscale in community samples with hip osteoarthritis.
    Pua YH, Cowan SM, Wrigley TV, Bennell KL.
    Arch Phys Med Rehabil; 2009 Oct 15; 90(10):1772-7. PubMed ID: 19801070
    [Abstract] [Full Text] [Related]

  • 30. Health-related quality of life and appropriateness of knee or hip joint replacement.
    Quintana JM, Escobar A, Arostegui I, Bilbao A, Azkarate J, Goenaga JI, Arenaza JC.
    Arch Intern Med; 2006 Jan 23; 166(2):220-6. PubMed ID: 16432092
    [Abstract] [Full Text] [Related]

  • 31. The VIOXX in Prostate Cancer Prevention study: cardiovascular events observed in the rofecoxib 25 mg and placebo treatment groups.
    van Adelsberg J, Gann P, Ko AT, Damber JE, Logothetis C, Marberger M, Schmitz-Drager BJ, Tubaro A, Harms CJ, Roehrborn C.
    Curr Med Res Opin; 2007 Sep 23; 23(9):2063-70. PubMed ID: 17651539
    [Abstract] [Full Text] [Related]

  • 32. Prospective analysis of clinical evaluation and self-assessment by patients after decompression surgery for degenerative lumbar canal stenosis.
    Haro H, Maekawa S, Hamada Y.
    Spine J; 2008 Sep 23; 8(2):380-4. PubMed ID: 17433781
    [Abstract] [Full Text] [Related]

  • 33. A naturalistic study of the determinants of health related quality of life improvement in osteoarthritic patients treated with non-specific non-steroidal anti-inflammatory drugs.
    Rabenda V, Burlet N, Ethgen O, Raeman F, Belaiche J, Reginster JY.
    Ann Rheum Dis; 2005 May 23; 64(5):688-93. PubMed ID: 15528282
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.
    Kivitz A, Fairfax M, Sheldon EA, Xiang Q, Jones BA, Gammaitoni AR, Gould EM.
    Clin Ther; 2008 Dec 23; 30(12):2366-77. PubMed ID: 19167595
    [Abstract] [Full Text] [Related]

  • 36. Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy Multinational Study Group.
    Hawkey C, Laine L, Simon T, Beaulieu A, Maldonado-Cocco J, Acevedo E, Shahane A, Quan H, Bolognese J, Mortensen E.
    Arthritis Rheum; 2000 Feb 23; 43(2):370-7. PubMed ID: 10693877
    [Abstract] [Full Text] [Related]

  • 37. A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis. Rofecoxib/Ibuprofen Comparator Study Group.
    Day R, Morrison B, Luza A, Castaneda O, Strusberg A, Nahir M, Helgetveit KB, Kress B, Daniels B, Bolognese J, Krupa D, Seidenberg B, Ehrich E.
    Arch Intern Med; 2000 Jun 26; 160(12):1781-7. PubMed ID: 10871971
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Efficacy and safety of rofecoxib 12.5 mg versus nabumetone 1,000 mg in patients with osteoarthritis of the knee: a randomized controlled trial.
    Kivitz AJ, Greenwald MW, Cohen SB, Polis AB, Najarian DK, Dixon ME, Moidel RA, Green JA, Baraf HS, Petruschke RA, Matsumoto AK, Geba GP, Protocol 085 Study Investigators.
    J Am Geriatr Soc; 2004 May 26; 52(5):666-74. PubMed ID: 15086644
    [Abstract] [Full Text] [Related]

  • 40. The effect of heat application on pain, stiffness, physical function and quality of life in patients with knee osteoarthritis.
    Yildirim N, Filiz Ulusoy M, Bodur H.
    J Clin Nurs; 2010 Apr 26; 19(7-8):1113-20. PubMed ID: 20492056
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.